CARE Ratings schedules board meeting on May 13, 2026 to approve audited standalone and consolidated financial results for Q4 and FY26.
Board will consider recommending final dividend for financial year 2025-26, subject to approval.
Trading window closure for company shares remains in effect from April 1, 2026 until 48 hours after results declaration.